US PATENT SUBCLASS 514 / 922
SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENT


Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use



514 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

922SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENT


DEFINITION

Classification: 514/922

SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENT:

Subject matter involving the reducing or eliminating of an undesirable side effect of a given drug by concurrent administration of a second designated compound.